RE:We're prepared to export cannabis to the U.S. medical marketThis interview was very eye opening! As the reporter pushed Irwin to respond to how the change in schedule in the US will change anything for Tilray, Irwin finally stated we will enter the market through the medical lane. He then went on and stated "if we can't, then we will find a way". That in itself is very telling, the only strategy is medical and he is not sure if that will be permissable. This is from the horses mouth. Under schedule 3 there is no other pathway into the US ccannabis market for Tilray. When pushed on how will Tilray break into the medical market against the well established US MSOs he explained they will be able to ship into the US with there expertise and know how using existing ditribution. Ok, great thats how you will ship, but how do you differentiate and take customers away from their current provider? Florida alone is bigger than Canada and is a medical market only with several big players now battling it out. TRUL for example still has about 70% of the market cornered in Florida and the other MSOs are slowly chipping away at that segmenrt, but it takes years and money. In reality, the real prize is recreational opening up in the state. Again, Tilray admitidly, will not be permitted to sell rec if/when Florida moves in that direction. Looking at Canada we know the medical market represents only 25% of the sales, so with incredibly fierce US competition and with the removal of 280e, the MSOs are making massive amounts of money selling rec in half the states wich represents 75% of the sales opportunity. How on earth could Tilray possibly be successful? Tilray has no tax break at home in Canada and are losing money rapidly at a time they need to make massive investments, so they are really behind the eight ball. Considering all this, and considering the stated back up plan into the USA is "we fillfigure out a way in" instills little confidence there is or will be a viable plan, and indicitive of the value in the guidance of a 30m/yr CEO. To ittle to late sitting on the wrong side of the fence for in my books. GLTA